Atala Financial Inc Invests $51,000 in The Cooper Companies, Inc. (NASDAQ:COO)

Atala Financial Inc bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 552 shares of the medical device company’s stock, valued at approximately $51,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. LBP AM SA lifted its holdings in shares of Cooper Companies by 6.7% during the fourth quarter. LBP AM SA now owns 49,913 shares of the medical device company’s stock worth $4,589,000 after buying an additional 3,116 shares in the last quarter. Impact Capital Partners LLC acquired a new position in Cooper Companies in the fourth quarter valued at about $741,000. Connor Clark & Lunn Investment Management Ltd. acquired a new position in Cooper Companies in the fourth quarter valued at about $1,984,000. EverSource Wealth Advisors LLC raised its stake in Cooper Companies by 9.0% in the fourth quarter. EverSource Wealth Advisors LLC now owns 6,297 shares of the medical device company’s stock valued at $579,000 after purchasing an additional 518 shares in the last quarter. Finally, Wealthfront Advisers LLC raised its stake in Cooper Companies by 4,594.1% in the fourth quarter. Wealthfront Advisers LLC now owns 569,812 shares of the medical device company’s stock valued at $52,383,000 after purchasing an additional 557,673 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Morgan Stanley dropped their price target on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research note on Friday, March 7th. Stifel Nicolaus dropped their price target on Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a research note on Friday, March 7th. StockNews.com downgraded Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Finally, JPMorgan Chase & Co. decreased their target price on Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a research report on Friday, March 7th. Three analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $111.89.

Cooper Companies Stock Performance

NASDAQ:COO opened at $81.22 on Friday. The stock has a market cap of $16.21 billion, a P/E ratio of 41.65, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The stock’s 50-day moving average is $91.20 and its 200-day moving average is $98.86. The Cooper Companies, Inc. has a 1-year low of $77.05 and a 1-year high of $112.38.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting the consensus estimate of $0.92. The company had revenue of $964.70 million for the quarter, compared to analysts’ expectations of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.